Author
Listed:
- Chikako Shimokawa
(National Institute of Infectious Disease
Gunma University
RIKEN Center for Integrative Medical Sciences)
- Tamotsu Kato
(RIKEN Center for Integrative Medical Sciences
Yokohama City University)
- Tadashi Takeuchi
(RIKEN Center for Integrative Medical Sciences
Keio University)
- Noriyasu Ohshima
(Gunma University)
- Takao Furuki
(Center for Biological Resources and Informatics, Tokyo Institute of Technology)
- Yoshiaki Ohtsu
(Gunma University)
- Kazutomo Suzue
(Gunma University)
- Takashi Imai
(Gunma University)
- Seiji Obi
(Gunma University)
- Alex Olia
(National Institute of Infectious Disease
Gunma University)
- Takashi Izumi
(Gunma University)
- Minoru Sakurai
(Center for Biological Resources and Informatics, Tokyo Institute of Technology)
- Hirokazu Arakawa
(Gunma University)
- Hiroshi Ohno
(RIKEN Center for Integrative Medical Sciences
Yokohama City University
Intestinal Microbiota Project, Kanagawa Institute of Industrial Science and Technology)
- Hajime Hisaeda
(National Institute of Infectious Disease
Gunma University)
Abstract
Type 1 diabetes (T1D) is an autoimmune disease in which insulin-producing pancreatic β-cells are destroyed. Intestinal helminths can cause asymptomatic chronic and immunosuppressive infections and suppress disease in rodent models of T1D. However, the underlying regulatory mechanisms for this protection are unclear. Here, we report that CD8+ regulatory T (Treg) cells prevent the onset of streptozotocin -induced diabetes by a rodent intestinal nematode. Trehalose derived from nematodes affects the intestinal microbiota and increases the abundance of Ruminococcus spp., resulting in the induction of CD8+ Treg cells. Furthermore, trehalose has therapeutic effects on both streptozotocin-induced diabetes and in the NOD mouse model of T1D. In addition, compared with healthy volunteers, patients with T1D have fewer CD8+ Treg cells, and the abundance of intestinal Ruminococcus positively correlates with the number of CD8+ Treg cells in humans.
Suggested Citation
Chikako Shimokawa & Tamotsu Kato & Tadashi Takeuchi & Noriyasu Ohshima & Takao Furuki & Yoshiaki Ohtsu & Kazutomo Suzue & Takashi Imai & Seiji Obi & Alex Olia & Takashi Izumi & Minoru Sakurai & Hiroka, 2020.
"CD8+ regulatory T cells are critical in prevention of autoimmune-mediated diabetes,"
Nature Communications, Nature, vol. 11(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15857-x
DOI: 10.1038/s41467-020-15857-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-15857-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.